Zai Lab Limited
HKEX:9688.HK
20.05 (HKD) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Zai Lab Limited |
Symbool | 9688.HK |
Munteenheid | HKD |
Prijs | 20.05 |
Beurswaarde | 19,873,074,790 |
Dividendpercentage | 0% |
52-weken bereik | 10.56 - 24.4 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Ying Du Ph.D. |
Website | https://www.zailaboratory.com |
An error occurred while fetching data.
Over Zai Lab Limited
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)